Position in PALI
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$25,504
New position
Shares Held
12,203
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 4 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026NorthCrest Asset Manangement, LLC holds $17,717,995 across 23 Biotechnology names. PALI ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,963 | $6,212,329 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
45,150 | $3,533,890 | |
| 3 | EXEL |
Exelixis, Inc.
|
28,794 | $1,566,681 | |
| 4 | INCY |
Incyte Corp
|
12,026 | $1,363,267 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
15,378 | $844,867 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,554 | $771,918 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
5,414 | $633,816 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
7,974 | $456,272 |
All Filings in PALI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,504 | 12,203 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||